Nils Erik Gilhus
Nils Erik Gilhus publishes mostly in Neurology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health, on topics such as Myasthenia Gravis and Thymoma, Peripheral Neuropathies and Disorders and Pharmacological Effects and Toxicity Studies.
- World rank
- #209,358 of 7,710,434 ranked researchers
- Rank in Norway
- #1,193 of 33,005
- Works
- 426
- Citations
- 19k
- Citations per work
- 44.5
What does Nils Erik Gilhus research?
Nils Erik Gilhus's work is mostly in Medicine (64%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences27163.7%
- Medicine27163.7%
- Everything else15536.3%
- 1Neurology37% of their works
- 2Psychiatry and Mental health7% of their works
- 3Pediatrics, Perinatology and Child Health7% of their works
- 4Public Health, Environmental and Occupational Health6% of their works
- 5Genetics4% of their works
- 6Surgery4% of their works
Research topics
- Myasthenia Gravis and Thymoma
- Peripheral Neuropathies and Disorders
- Pharmacological Effects and Toxicity Studies
- Epilepsy research and treatment
- Parkinson's Disease and Spinal Disorders
- Pregnancy and Medication Impact
- Autoimmune Neurological Disorders and Treatments
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Which keywords describe Nils Erik Gilhus's research?
The keywords of their largest research topics: Prognosis, Autoantibodies, Immunotherapy, Myasthenia Gravis, Thymic Tumors, Neurological Disorders, Antiepileptic Drugs and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
- Kinin Receptor Family
- Paraneoplastic Syndromes
- Pregnancy
- Parkinson's Disease
- Seizures
- Prenatal Exposure
- Teratogenicity
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Neurological Disorders
- Myasthenia Gravis
- Autoantibodies
- Prognosis
- Immunotherapy
- Thymic Tumors
- Antiepileptic Drugs
- Guillain-Barré Syndrome
- Neurodevelopmental Disorders
- Epilepsy
- Camptocormia
- Medication Use
- Anti-NMDA Receptor Encephalitis
- Hereditary Angioedema
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Prognosis3122 topics
- Autoantibodies2342 topics
- Immunotherapy2342 topics
- Myasthenia Gravis2021 topic
- Thymic Tumors2021 topic
- Neurological Disorders1833 topics
- Antiepileptic Drugs1152 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy1101 topic
- Guillain-Barré Syndrome1101 topic
- Teratogenicity1012 topics
- Neurodevelopmental Disorders631 topic
- Prenatal Exposure631 topic
- Epilepsy521 topic
- Seizures521 topic
- Camptocormia411 topic
- Parkinson's Disease411 topic
- Medication Use381 topic
- Pregnancy381 topic
- Anti-NMDA Receptor Encephalitis321 topic
- Paraneoplastic Syndromes321 topic
- Hereditary Angioedema281 topic
- Kinin Receptor Family281 topic
Where does Nils Erik Gilhus work?
Nils Erik Gilhus's main affiliation in the publication record is University of Bergen, Norway.
How many publications and citations does Nils Erik Gilhus have?
OpenAlex counts 426 works and 18,972 citations for Nils Erik Gilhus, an h-index of 67, ranking #209,358 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nils Erik Gilhus. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.